PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Eine durchschnittliche Folge dieses Podcasts dauert 22m.
Bisher sind 128 Folge(n) erschienen.
Alle zwei Wochen gibt es eine neue Folge dieses Podcasts.
Gesamtlänge aller Episoden: 2 days 6 hours 13 minutes
Novel Strategies for Intensifying Basal Insulin Therapy in Type 2 Diabetes: The Role of GLP-1 Receptor Agonists
Go online to www.peervoice.com/h/pve79 to view the entire programme with slides.
Journal Club: Exploring the Impact of Hypothyroidism on Cognitive and Motor Function in Patients With Thyroid Cancer
Go online to www.peervoice.com/h/pvj24 to view the entire programme with slides.
Using SGLT2 Inhibitors in Your Practice: What the Specialists, GPs, and Pharmacists Need to Know
Go online to www.peervoice.com/h/pve73 to view the entire programme with slides.
Acromegaly and Cushing’s Disease: Managing the Intersection of Pathology and Treatment
Go online to www.peervoice.com/h/pve87 to view the entire programme with slides.
Combination Therapy for Type 2 Diabetes: The Emerging Role of SGLT2 Inhibition
Combination Therapy for Type 2 Diabetes: The Emerging Role of SGLT2 Inhibition
Early Detection of Mucopolysaccharidosis: Recognising the Key Symptoms From a Paediatric Otolaryngology Perspective
Go online to www.peervoice.com/h/pvr180 to view the entire programme with slides.
An Individualized Approach to Therapy With DPP-4 Inhibitors
An Individualized Approach to Therapy With DPP-4 Inhibitors
An Individualized Approach to Therapy With DPP-4 Inhibitors
An Individualized Approach to Therapy With DPP-4 Inhibitors